The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Cancer incidence in patients with schizophrenia and their first‐degree relatives – a meta‐analysis
Abstract
Objective: Controversy concerning cancer incidence in schizophrenia exists because of heterogeneous study findings. Method: A meta‐analysis was performed on standardized incidence ratios (SIR) of cancer in patients with schizophrenia and first‐degree relatives and compared with general population samples. Results: The pooled overall cancer incidence in patients was not significantly increased (SIR = 1.05, CI 0.95–1.15). Lung cancer incidence was slightly increased (SIR = 1.31, CI 1.01–1.71), but was reduced after adjusting for smoking prevalence. The incidence of several cancers unrelated to smoking was reduced in patients. Breast cancer rates were significantly increased in female patients. The pooled overall cancer incidence in siblings (SIR = 0.89, CI 0.84–0.94) and parents (SIR = 0.90, CI 0.88–0.93) was significantly reduced. A meta‐regression detected a significant relationship between cancer risk in the general population and relative risk in patients. Conclusion: The meta‐analysis aided exploration of inconsistent study findings. There is a discrepancy between cancer risk exposure and cancer incidence in schizophrenia consistent with a protective effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, other studies found an increased (9,21,28,(449)(450)(451) or no different (292,419,452,453) overall risk of cancer in patients with schizophrenia compared to the general population.”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [453]
Citations
Cites
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Meta-analysis Spurious precision? Meta-analysis of observational studies
Egger, M., Schneider, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7125.140 · Cited by 997
Medical Comorbidity in Schizophrenia
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.413 · Cited by 617
Medical complications of anorexia nervosa and bulimia nervosa
Mitchell, J. E., & Crow, S. J. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000228768.79097.3e · Cited by 495
Mortality and Causes of Death in First Admitted Schizophrenic Patients
Mortensen, P. B., & Juel, K. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.2.183 · Cited by 412
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 372
Greenland, S. (2001) · Biostatistics · doi:10.1093/biostatistics/2.4.463 · Cited by 359
Shapiro, S. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117324 · Cited by 354
Medical comorbidity in women and men with schizophrenia: A population-based controlled study
Carney, C. P., Jones, L., & Woolson, R. F. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00563.x · Cited by 343
Research works printed but not linked: 7
- Cochrane Collaboration, 2006, Review manager (RevMan) [Computer program]
- Nakane Y, 1986, Psychiatric case registers in public health, 240
- Dupont A, 1986, Psychiatric case registers in public health, 229
- Mackay J, 2006, The cancer atlas
- Higgins JPT, 2006, Skewed data 8.5.2.11, in Cochrane handbook for systematic reviews of interventions 4.2.6 [Updated September 2006]
- Catts VS, 2007, No in vitro anti‐cancer effect of antipsychotic drugs at doses used in the psychiatric clinic, Schizophr Bull, 33, 230
- Mortensen PB, 1987, Cancerdiagnostic og autopsifrekvens blandt schizofrene patienter, Ugeskr Laeger, 149, 1973
Cited by
Sorted by citations
Items 101–200 of 208
Sei, Y., Li, Z., Song, J., Ren‐Patterson, R. F., Tunbridge, E. M., Iizuka, Y., Inoue, M., Alfonso, B. T., Beltaifa, S., Nakai, Y., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010789 · Cited by 21
Gervaix, J., Haour, G., Michel, M., & Chevreul, K. (2018) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796018000203 · Cited by 21
Psychiatric Disorder as a Risk Factor for Cancer
Whitley, E., Batty, G. D., Mulheran, P. A., Galé, C. R., Osborn, D., Tynelius, P., & Rasmussen, F. E. (2012) · Epidemiology · doi:10.1097/ede.0b013e3182547094 · Cited by 20
Cancer in parents of persons with schizophrenia: Is there a genetic protection?
Gal, G., Goral, A., Murad, H., Gross, R., Pugachova, I., Barchana, M., Kohn, R., & Levav, I. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.04.018 · Cited by 21
Tada, Y., Matsubara, M., Kawada, S., Ishida, M., Wada, M., Wada, T., & Onishi, H. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyr200 · Cited by 20
Murphy, K. A., Daumit, G. L., Bandara, S. N., Stone, E. M., Kennedy‐Hendricks, A., Stuart, E. A., Pollack, C. E., & McGinty, E. E. (2020) · Psychiatric Services · doi:10.1176/appi.ps.201900299 · Cited by 20
Kuć, M., Cieślik-Boczula, K., Świątek, P., Jaszczyszyn, A., Gąsiorowski, K., & Malinka, W. (2015) · Chemical Physics · doi:10.1016/j.chemphys.2015.06.010 · Cited by 20
O’Brien, M. T., Oakhill, J. S., Ling, N. X. Y., Langendorf, C. G., Hoque, A., Dite, T. A., Means, A. R., Kemp, B. E., & Scott, J. W. (2017) · Scientific Reports · doi:10.1038/srep43264 · Cited by 19
Xu, D., Chen, G., Kong, L., Zhang, W., Hu, L., Chen, C., Li, J., & Zhuo, C. (2017) · Oncotarget · doi:10.18632/oncotarget.21679 · Cited by 19
Arffman, M., Manderbacka, K., Suvisaari, J., Koivunen, J. P., Lumme, S., Keskimäki, I., Ahlgrén-Rimpiläinen, A., & Pukkala, . (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.06.018 · Cited by 18
The risk for cancer among patients with schizoaffective disorders
Levav, I., Kohn, R., Barchana, M., Lipshitz, I., Pugachova, I., Weizman, A., & Grinshpoon, A. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.010 · Cited by 18
Stolz, P. A., Wehring, H. J., Liu, F., Love, R. C., Ellis, M., DiPaula, B. A., & Kelly, D. L. (2019) · Psychiatric Quarterly · doi:10.1007/s11126-018-9621-4 · Cited by 18
Preti, A., & Wilson, D. R. (2011) · Psychiatry Investigation · doi:10.4306/pi.2011.8.2.77 · Cited by 18
Ajdacic‐Gross, V., Rodgers, S., Aleksandrowicz, A., Mütsch, M., Steinemann, N., von Wyl, V., von Känel, R., & Bopp, M. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.08.018 · Cited by 17
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer
van der Horst, G., van de Merbel, A. F., Ruigrok, E. A. M., van der Mark, M. H., Ploeg, E. M., Appelman, L., Tvingsholm, S. A., Jäätelä, M., van Uhm, J. I. M., Julio, M. K., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12793 · Cited by 16
Ren, F., Shang, Q., Zhao, S., Yang, C., Feng, K., Liu, J., Kang, X., Zhang, R., Wang, X., & Wang, X. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1179562 · Cited by 17
Pankiewicz-Dulacz, M., Stenager, E., Chen, M., & Stenager, E. N. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120485 · Cited by 15
The Risk and The Course of Cancer Among People with Severe Mental Illness
Grassi, L. G., McFarland, D. C., & Riba, M. (2022) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/17450179-v17-e211208-2021-ht2-1910-8 · Cited by 15
The Pivotal Roles of GSK3β in Glioma Biology
Nakada, M., Minamoto, T., Ilya, V. V., Hayashi, Y., & Ham, J.-I. (2011) · InTech eBooks · doi:10.5772/21458 · Cited by 14
miRNAs and their role in the correlation between schizophrenia and cancer
Rizos, E. N., Siafakas, N., Skourti, E., Papageorgiou, C., Tsoporis, J. N., Parker, T. H., Christodoulou, D. I., Spandidos, D. A., Katsantoni, E. Z., & Zoumpourlis, V. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5853 · Cited by 15
Candidate Gene Studies in the GWAS Era: The MET Proto-Oncogene, Neurocognition, and Schizophrenia
Cannon, T. D. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10010082 · Cited by 14
Challenges in Treating Cancer Patients With Unstable Psychiatric Disorder
Bellman, V., Russell, N., Depala, K., Dellenbaugh, A., Desai, S. R., Vadukapuram, R., Patel, S., & Srinivas, S. (2021) · World Journal of Oncology · doi:10.14740/wjon1402 · Cited by 13
Genetic trade‐offs between complex diseases and longevity
Hu, D., Li, Y., Zhang, D., Ding, J., Song, Z., Min, J., Zeng, Y., & Nie, C. (2022) · Aging Cell · doi:10.1111/acel.13654 · Cited by 13
Wang, Y., He, G., He, L., & McGrath, J. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.009 · Cited by 13
Wang, Y., Cao, Y., Huang, X., Yu, T., Wei, Z., McGrath, J. J., Xu, F., Bi, Y., Li, X., Yang, F., et al. (2016) · Scientific Reports · doi:10.1038/srep26688 · Cited by 13
Foley, D. L., Mackinnon, A. J., Morgan, V. A., Watts, G. F., Shaw, J. E., Magliano, D. J., Castle, D. J., McGrath, J. J., Waterreus, A. J., & Galletly, C. A. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414565476 · Cited by 12
Lawrence, D., Hancock, K., & Kisely, S. R. (2014) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000365541 · Cited by 12
Etoh, T., Fujiwara, M., Yamada, Y., Wada, R., Higuchi, Y., Inoue, S., Kodama, M., Matsushita, T., Yoshimura, Y., Horii, S., et al. (2021) · Psycho-Oncology · doi:10.1002/pon.5780 · Cited by 11
Zhang, H., Li, D., Su, Y., Jiang, S., Xu, Y., Jiang, K., & Cui, D. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.559273 · Cited by 11
Chen, L., Hung, Y., Chen, Y., Yang, S., Pan, C. H., Chen, C., & Kuo, C. J. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000883 · Cited by 11
Ajdacic‐Gross, V., Tschopp, A., Bopp, M., Gutzwiller, F., & Wulf Rössler, A. (2014) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1432 · Cited by 11
Brown, J. S. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw064 · Cited by 11
Schizophrenia and cancer: Is angiogenesis a missed link?
Lopes, R., Soares, R. A., Figueiredo‐Braga, M., & Coelho, R. C. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.12.023 · Cited by 10
Kisely, S. R., Campbell, L. A., & Cox, M. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700609 · Cited by 10
Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?
Hamoud, A.-R. A., Bach, K., Kakrecha, O., Henkel, N., Wu, X., McCullumsmith, R. E., & O'Donovan, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911835 · Cited by 8
Scientific Research and Corporate Influence: Smoking, Mental Illness, and the Tobacco Industry
Hirshbein, L. (2011) · Journal of the History of Medicine and Allied Sciences · doi:10.1093/jhmas/jrr019 · Cited by 8
Catalá-López, F., Hutton, B., Driver, J. A., Ridao-López, M., Valderas, J. M., Gènova-Maleras, R., Forés-Martos, J., Alonso‐Arroyo, A., Saint-Gerons, D. M., Vieta, E., et al. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0540-5 · Cited by 8
Cancer prevalence in Israeli men and women with schizophrenia
Agay, N., Flaks‐Manov, N., Nitzan, U., Hoshen, M., Levkovitz, Y., & Munitz, H. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.082 · Cited by 8
Improving Breast Cancer Screening and Care for Women With Severe Mental Illness
Hwong, A. R., & Mangurian, C. V. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.0462 · Cited by 8
Wootten, J. C., Richard, L., Blanchette, P., Wiener, J., & Anderson, K. K. (2022) · Psycho-Oncology · doi:10.1002/pon.5983 · Cited by 7
Prostate Cancer Related JAZF1 Gene is Associated with Schizophrenia.
Wang, K., Zuo, L., Owusu, D., Pan, Y., & Luο, X. (2014) · PubMed · Cited by 7
“Gestaltomics”: Systems Biology Schemes for the Study of Neuropsychiatric Diseases
Gutiérrez-Nájera, N., Reséndis-Antonio, O., & Nicolini, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00286 · Cited by 8
Mental Health, Mitochondria, and the Battle of the Sexes
Bressan, P., & Krämer, P. (2021) · Biomedicines · doi:10.3390/biomedicines9020116 · Cited by 7
The Importance of Negative Comorbidity
Tabarés‐Seisdedos, R., Gómez-Beneyto, M., Haro, J. M., González-Pinto, A. M., & Vieta, E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08lr04991 · Cited by 7
Reduced risk of cancer in schizophrenia: a role for obstetric complications?
Preti, A. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01235.x · Cited by 7
Excess mortality from cancer in people with mental illness—Out of sight and out of mind
Kisely, S. R., & Siskind, D. J. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13363 · Cited by 7
Uwai, Y., & Nabekura, T. (2024) · Drugs - Real World Outcomes · doi:10.1007/s40801-024-00417-2 · Cited by 6
Two-sample Mendelian randomization study for schizophrenia and breast cancer
Kim, S., Kim, K., Myung, W., Lee, H., Kim, H., Kim, D. K., & Won, H. (2020) · Precision and Future Medicine · doi:10.23838/pfm.2019.00093 · Cited by 6
Augmenting disease maps: a Bayesian meta-analysis approach
Jahan, F., Duncan, E. W., Cramb, S. M., Baade, P. D., & Mengersen, K. L. (2020) · Royal Society Open Science · doi:10.1098/rsos.192151 · Cited by 6
Bhimani, F., McEvoy, M. P., Chen, Y., Gupta, A. M., Pastoriza, J. M., Fruchter, S., Bitan, Z. C., Tomé, W. A., Mehta, K., Fox, J. L., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1429326 · Cited by 5
Increased Lymphocyte Caspase-3 Activity in Patients with Schizophrenia
Lazarevic, D. S., Đorđević, V. V., Ćosić, V., Vlahović, P., Tošić-Golubović, S., Ristić, T., & Đorđević, V. B. (2010) · Journal of Medical Biochemistry · doi:10.2478/v10011-011-0002-x · Cited by 5
Clozapine and anti-cancer agents: a systematic literature review of case reports
Honor, A., Parmenter, J., Marsh, R., Siskind, D. J., & Warren, N. (2025) · CNS Spectrums · doi:10.1017/s1092852925100576 · Cited by 4
Tylec, A., Dubas-Ślemp, H., Wójcicka, A., Drop, B., & Kucharska, K. (2018) · Psychiatria Polska · doi:10.12740/pp/69142 · Cited by 4
Reduced Risk of Cancer in Patients with Bipolar Affective Disorder
Rosenshfir, E., Shemesh, P., Aizenberg, D., & Barak, Y. (2011) · Neuroscience & Medicine · doi:10.4236/nm.2011.21008 · Cited by 4
Assessment of Co-occurring Addictive and Other Mental Disorders
Kavanagh, D. J., & Connolly, J. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374348-0.00005-7 · Cited by 4
Smoking Bans and Persons with Schizophrenia: A Straightforward Use of the Harm Principle?
Silva, D. S. (2011) · Public Health Ethics · doi:10.1093/phe/phr021 · Cited by 4
Chen, S., Du, Z., Qin, Y., Li, Y., Pan, Y., Qiao, Y., Chen, J., Hou, Z., Jin, S., Tao, H., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1338481 · Cited by 3
Cancer characteristics in patients with schizophrenia: a 25-year retrospective analysis
Casanovas, F., Dinamarca, F., Posso, M., Mané, A., Oller, S., Córcoles, D., Macià, F., Sala, M., Pérez, V., & Ruiz, A. I. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116206 · Cited by 3
Increased serum levels of spectrin degradation products in patients with schizophrenia
Çetin, İ., & Demirel, Ö. F. (2018) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2017-0142 · Cited by 3
Farré, X., Spataro, N., Haziza, F., Rambla, J., & Navarro, A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz622 · Cited by 3
Osman, A. H. M., Abdalhai, K. A., Hassan, I., Elmubark, M. A., & Elawad, L. A. (2020) · Middle East Current Psychiatry · doi:10.1186/s43045-020-00052-x · Cited by 4
Schizophrenia and Cancer: Low Incidence, High Mortality
Seeman, M. V. (2017) · Cited by 3
Cancer Risk Before Schizophrenia Diagnosis in Taiwan, 1995-2009
Chen, Y.-J., Lin, G., & Li, Y.-H. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt053 · Cited by 3
Incidence and Outcomes of Head and Neck Cancer in Patients With Schizophrenia
Wenger, T. A., Wong, S. J., Cheng, S., Tang, L., Kwon, D. I., Kokot, N., Chai, Y., Sinha, U. K., & Han, A. Y. (2025) · OTO Open · doi:10.1002/oto2.70164 · Cited by 2
Soins palliatifs et situations psychiatriques chroniques : questionnement à partir d’un cas clinique
Rhondali, W., Perceau-Chambard, É., & Filbet, M. (2010) · Médecine Palliative · doi:10.1016/j.medpal.2010.03.006 · Cited by 2
Deciphering the paradoxical incidence of cancer in schizophrenia
Kuppili, P. P., & Nebhinani, N. (2018) · Australasian Psychiatry · doi:10.1177/1039856218797439 · Cited by 2
Impact of Hyperprolactinaemia on the General Health of Patients with Schizophrenia
Wildgust, H. J., & Kohen, D. (2008) · Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry · doi:10.1159/000189779 · Cited by 2
Phosphoinositide-Dependent Protein Kinase 1 (PDK1)
Lang, U. E., Ackermann, T. F., Wolfer, D. P., Schubert, F., Sohr, R., Hörtnagl, H., Lang, F. J. W., & Gallinat, J. (2015) · Zeitschrift für Psychologie · doi:10.1027/2151-2604/a000217 · Cited by 2
The Interaction Between Melanoma and Psychiatric Disorder
Kisely, S. R., Lawrence, D. M., Kelly, G., Pais, J., & Crowe, E. (2011) · InTech eBooks · doi:10.5772/19020 · Cited by 2
Complications of neuroleptic hyperprolactinaemia
Mazo, G. E., & Николаевна, Г. Л. (2018) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2018-2-104-108 · Cited by 2
Psychological structure of alexithymic space in patients with cardiovascular diseases
Brel, E. Y., Bokhan, N. A., & Stoyanova, I. Y. (2018) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2018-2-90-96 · Cited by 2
Meeting the challenge of physical comorbidity and unhealthy lifestyles
Burti, L., Berti, L., Bonfioli, E., & Fiorini, I. (2013) · Wiley eBooks · doi:10.1002/9781118337981.ch8 · Cited by 2
Doença Somática nas Pessoas com Doença Mental Grave
Martins, D. O., Rodrigues, S., Pinho, M., & Pereira, E. G. (2022) · Revista Portuguesa de Psiquiatria e Saúde Mental · doi:10.51338/rppsm.375 · Cited by 1
Cancer in Severe Mental Illness Patients: A Retrospective Study
Vinais, T., Gellé, T., Preux, P., Nubukpo, P., & Lacroix, A. (2025) · Psycho-Oncology · doi:10.1002/pon.70183 · Cited by 1
Anti-neoplastic effects of the antipsychotic drug penfluridol in preclinical prostate cancer models
van de Merbel, A. F., van der Mark, M. H., Aalders, T. W., Puhr, M., Mehra, N., Schalken, J. A., van der Horst, G., & van der Pluijm, G. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1685758 · Cited by 1
Daganatos megbetegedések incidenciája és mortalitása szkizofréniában, ellátórendszeri kihívások
Bohus, B., & Kegye, A. (2026) · Orvosi Hetilap · doi:10.1556/650.2026.33573 · Cited by 1
Peng, H., Jiang, B., Zhao, J., Chen, B., & Wang, P. (2015) · Tumor Biology · doi:10.1007/s13277-015-3087-x · Cited by 1
RetractedLower risk of prostate cancer in schizophrenia: fact or artifact?
Gal, G., Munitz, H., & Levav, I. (2014) · The European Journal of Psychiatry · doi:10.4321/s0213-61632014000400002 · Cited by 1
Mongelli, F., Mongelli, F., Hakeem, I. J., & Hodges, N. J. (2020) · Clinical Oncology and Research · doi:10.31487/j.cor.2020.02.03 · Cited by 1
Giant conjunctival melanoma in a paranoid schizophrenic man: A case report
Supit, T., Pujisriyani, Subiyakto, Nugroho, T., Fitrikasari, A., & Najatullah (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.01.069 · Cited by 1
Severe Mental Disorders and Cancer
Filipčić, I. Š., Grassi, L. G., & Filipčić, I. (2025) · Springer eBooks · doi:10.1007/978-3-031-81802-8_9 · Cited by 1
Schizophrenia Spectrum Disorders and Risk for Cancer Morbidity and Mortality
Ponizovsky, A. M., Weizman, A., & Grinshpoon, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0831-0_19 · Cited by 1
Reduced Risk of Cancer in Schizophrenia, a Bridge Toward Etio-Pathology and Therapy of Both Diseases
Eskandari, M. R., Abdolmaleky, H. M., Zhou, J., & Thiagalingam, S. (2015) · Springer eBooks · doi:10.1007/978-94-017-9639-2_5 · Cited by 1
Takehara, T., Tani, T., Takiue, H., Takeshita, R., Iwamaru, A., Yamamoto, T., & Koh, H. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.1974 · Cited by 1
Male Breast Carcinoma after Irradiation and Long-Term Phenothiazine Exposure: A Case Report
Hultborn, R., Parris, T. Z., Helou, K., Borg, Å., Lara, S. D., & Kovács, A. (2020) · Case Reports in Oncology · doi:10.1159/000509074 · Cited by 1
Baklouti, E., Karoui, M., Kammoun, R., & Ellouze, F. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5247
Epidemiology and management of depression in cancer patients
Ng, C. (2012) · Utrecht University Repository (Utrecht University) · Cited by 1
Bipolar Disorder and Safety Monitoring for Clinicians: A Review of the Evidence and the Implications
Bushe, C., & Tohen, M. F. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch28 · Cited by 1
Prolactin and Schizophrenia, an Evolving Relationship
Chris, J., & Pendlebury, J. (2011) · InTech eBooks · doi:10.5772/23484
The DISC1 genetic pathway and its role in Schizophrenia development
Yengej, D. Y. (2012) · Utrecht University Repository (Utrecht University)
Management of Comorbid Medical Conditions in Schizophrenia
Rado, J. T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0656-7_10
Reply to The Importance of Negative Comorbidity
Leucht, S., & Fleischhacker, W. W. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08lr04991a
Lorenzo, R. D. (2013) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2013/4825
Problems in management of breast cancer with serious mental illness
Byun, J., Ra, Y.-M., Kwon, S., Moon, J., Lee, S., Choi, I., Choi, W. J., Min, H. S., & Yoon, D.-S. (2013) · Korean Journal of Clinical Oncology · doi:10.14216/kjco.13026
Vladimir, V. H., Vlahovi, P., Risti, T., & Vidosava, B. (2011)
Prostate Cancer Related JAZF1 Gene is Associated with
Pan, Y., Luο, X., & Wang, K. (2014)
Health, Health Care and the Right to Health
(2012) · Wiley eBooks · doi:10.1002/9781119945352.ch9
Protection juridique et soins sans consentement chez le majeur hospitalisé en psychiatrie
Bougon, E. (2015) · HAL
Maj, M., Ïðåçèäåíò, È., Tasman, A., & Herrman, H. (2011)
Glineur, C. (2016) · Psycho-Oncologie · doi:10.1007/s11839-016-0596-9
Metadata
- Authors
- Catts, V. S., Catts, S. V., O’Toole, B. I., & Frost, A. D. J.
- Affiliations
- The University of Queensland (AU)
- The University of Sydney (AU)
- Royal Brisbane and Women's Hospital (AU)
- Corresponding author
- Catts, V. S.
- Catts, S. V.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2008-03-10
- Volume
- 117
- Issue
- 5
- Pages
- 323-336
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W1965388866
- Cited by
- 209
- References
- 63
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 3 · 2022: 8 · 2021: 11 · 2020: 11 · 2019: 8 · 2018: 15 · 2017: 14 · 2016: 12 · 2015: 12 · 2014: 18 · 2013: 15 · 2012: 13
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Psychiatrica Scandinavica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- schizophrenia, cancer incidence, lung cancer, breast cancer, first-degree relatives, siblings, parents, smoking, standardized incidence ratio, cancer risk
- MeSH terms
- Aged, Urinary Bladder Neoplasms, Humans, Lung Neoplasms, Neoplasms, Risk Factors, Schizophrenia, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review